Stay updated on Moderna Press Releases

Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Moderna Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    New press release items and dates were added to the News & Blog Posts section, expanding 2026–2028 coverage; at the same time, the header stock price and volume values were removed.
    Difference
    8%
    Check dated 2026-08-16T01:29:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now reflects the latest stock data and adds two significant press releases (FDA approval for mFLUSIVA and a Phase 1 trial initiation), while older stock figures and a prior press release were removed.
    Difference
    5%
    Check dated 2026-08-08T23:22:57.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows updated stock data and adds a new press release entry for Moderna's Q2 2026 results dated July 31, 2026, while removing the previous stock figures and an earlier press release from June 1, 2026.
    Difference
    1%
    Check dated 2026-08-01T17:47:18.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Moderna's stock quote and trading volume on the page were updated from $61.82 and 4.55M to $54.07 and 4.43M, respectively.
    Difference
    0.5%
    Check dated 2026-07-25T13:00:25.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page adds an updated stock quote ($61.82) and trading volume (4.55M) and includes a new press release headline dated July 16, 2026 announcing the first participant dosed in a Phase 1 trial evaluating an investigational tumor-targeted cancer antigen therapy in solid tumors.
    Difference
    1%
    Check dated 2026-07-18T09:16:45.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added: Q2 2026 financial results announcement, appointment of Michael McDonnell to Moderna's Board of Directors, and updated stock data (price 68.27, volume 9.18M) with dates July 9 and 8, 2026. Removed: the prior stock price (79.76) and two May 2026 press releases (TIME recognition and NEJM publication).
    Difference
    5%
    Check dated 2026-07-11T06:24:19.000Z thumbnail image

Stay in the know with updates to Moderna Press Releases

Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.